News

The BREATHE-3 trial is a pioneering phase 3 pivotal clinical study investigating the impact of a novel, experimental device designed to open the airways within a patient’s lungs and release trapped air in patients battling severe emphysema and COPD. 

Experts at the UAB Cardiovascular Institute and UAB St. Vincent’s say it is never too early or too late for women to begin protecting themselves from heart disease.

Research published in the journal Gut suggests that nutraceutical strategies restoring tryptophan metabolism and IPA levels may serve as both biomarkers and therapeutic approaches for diabetic retinopathy.

Procedures that remove plaque from a narrowed carotid artery in the neck or prop the artery open with a stent did not appear to be better at improving cognitive function than medications and lifestyle changes. 

Veterans who experienced homelessness and received care in H-PACTs were more likely to consistently see the same primary care provider. 

IncRNAs act like “switches,” turning off functionality for more than 3,000 genes that are essential for healthy brain functioning.

One UAB expert shares tips on preventing injuries and explains the benefits of hot and cold therapies in muscle recovery periods. 

UAB researchers share a discovery that could pave the way for non‑addictive alternatives to opioid painkillers amid an era of rising overdose deaths.

By bringing food directly into neighborhoods, Live HealthSmart Alabama continues its mission to make good health simple, one community at a time.

The clinical trial represents a major step forward in finding new solutions for people living with treatment-resistant depression. 

UAB has completed more than 16,000 organ transplants since 1968.

UAB researchers discovered that multiple myeloma is more common in men than in women through the Integrative Molecular and Genetic Epidemiology study.